[UPDATED] Mayo-Backed Personalized Medicine Startup OneOme Raises $5.25m


[Updated 10/4 @4:30 CST – OneOme CFO Mark Sylvester says the oversubscribed round is closed at $5.25m and the company is actively selling into the market now]

Minneapolis-based OneOme has raised $530k of a $600k equity funding round, according to this SEC disclosure.

Formed in 2013, OneOme works with physicians who place orders for patient test kits that the physician administers or are sent to directly the patient and back to the lab for DNA and  bioinformatics analysis. This generates a personalized pharmacogenomic report in under 2 weeks at a cost of $249. Soon,  this process will be integrated directly into the EMR experience.

OneOme is part of the Inveshure portfolio and co-developed in collaboration with algorithm IP from the Mayo Clinic.  It is estimated that OneOme has now received $8m+ in capitalization to date.

Watch OneOme cofounder Troy Kopischke present last year at MinneAnalytics Halicon


Big Data Genomics Startup OneOme Quietly Raises More Cash
Mayo and Invenshure launch genomics platform Oneome